StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Botox Therapeutic (onabotulinumtoxinA) by Quarter

Botox Therapeutic (onabotulinumtoxinA) — International net revenues ($M) ($M)

QuarterlyAnnual

AbbVie Botox Therapeutic (onabotulinumtoxinA): $178M in Q2 2026, up 16.3% from a year earlier. That is the highest of the 29 quarters on record here.

Latest, Q2 2026
178
Period ended Jun 30, 2026
Change on a year earlier
+16.3%
153 in Q2 2025
History
29 quarters
Since Q2 2019
Sources
24
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-03) ↗

Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBotox Therapeutic (onabotulinumtoxinA) — International net revenues ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026178+16.3%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 2026167+16.8%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 2025162+13.3%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 2025160+14.3%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025153+5.5%Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 2025143+4.4%Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 2024143+12.6%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 2024140+14.8%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 2024145+8.2%Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 2024137+3.8%Form 10-Q (filed 2025-05-09) ↗
Q4 2023Dec 31, 2023127+11.4%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 2023122+6.1%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jun 30, 2023134+10.7%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023132+15.8%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 2022114+3.6%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 2022115+3.6%Form 10-Q (filed 2023-11-06) ↗

Breakdown

What makes up botox Therapeutic (onabotulinumtoxinA)

Cite this data

StockData. (2026). AbbVie Botox Therapeutic (onabotulinumtoxinA) ($M), quarterly Q2 2019–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/botox-ther-intl

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.